Penny Stock Insider Trading
Tracking Executive Conviction in Stocks Under $5
Insider Activity in Low-Priced Equities
Insider trading in penny stocks often carries significant weight due to the high volatility inherent in smaller companies. When a director or CEO of a low-cap firm purchases shares, it can signal a major belief in an upcoming fundamental shift.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-14 01:11 | 2026-02-13 | TSI | TCW STRATEGIC INCOME FUND INC | McMillan Peter | Director | Other | BUY | $4.71 | 17,390 | $81,907 | 217,390 | +8.7% |
| 2026-02-14 01:12 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | Carmines Edward | Director | Medicinal Chemicals & Botanical Products | BUY | $0.20 | 250,000 | $50,000 | 2,156,481 | +13.1% |
| 2026-02-14 01:19 | 2026-02-13 | CHUC | Charlie's Holdings, Inc. | King Michael D | Director | Medicinal Chemicals & Botanical Products | BUY | $0.20 | 500,000 | $100,000 | 6,750,001 | +8.0% |
| 2026-02-14 01:20 | 2026-02-11 | SNES | SenesTech, Inc. | GLENBROOK CAPITAL MANAGEMENT | 10% owner | Agricultural Chemicals | BUY | $1.81 | 31,346 | $56,667 | 633,700 | +5.2% |
| 2026-02-14 00:45 | 2026-01-09 | STSS | Sharps Technology Inc. | FalconX Holdings Ltd | 10% owner | Surgical & Medical Instruments & Apparatus | SELL | $1.94 | 769,320 | -$1,490,788 | 0 | -100.0% |
| 2026-02-14 00:15 | 2026-02-11 | TPET | Trio Petroleum Corp | Ross Robin A. | Director, Officer - Chief Executive Officer | Crude Petroleum & Natural Gas | SELL | $0.00 | 25,000 | $0 | 712,500 | -3.4% |
| 2026-02-14 00:15 | 2026-02-12 | TPET | Trio Petroleum Corp | PERNICE THOMAS J | Director | Crude Petroleum & Natural Gas | SELL | $0.00 | 25,000 | $0 | 217,750 | -10.3% |
| 2026-02-14 00:04 | 2026-02-11 | NRX | Neuraxis, INC | Hannasch Brian | 10% owner | Electromedical & Electrotherapeutic Apparatus | BUY | $4.79 | 80,000 | $382,800 | 1,211,522 | +7.1% |
| 2026-02-13 19:08 | 2026-02-10 | RBBN | Ribbon Communications Inc. | McClelland Bruce William | Director, Officer - President & CEO | Services-Computer Integrated Systems Design | BUY | $2.01 | 37,000 | $74,307 | 1,516,164 | +2.5% |
| 2026-02-13 19:02 | 2026-02-12 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.73 | 1,134 | $3,096 | 65,646 | +1.8% |
| 2026-02-13 18:05 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $0.37 | 388,532 | $145,000 | 8,861,914 | +4.6% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Andrews Patricia S | Director | Pharmaceutical Preparations | BUY | $0.86 | 35,400 | $30,292 | 78,128 | +82.8% |
| 2026-02-13 15:00 | 2026-02-11 | ONCY | ONCOLYTICS BIOTECH INC | Aromando Andrew | Officer - Chief Business Officer | Pharmaceutical Preparations | BUY | $0.86 | 29,600 | $25,418 | 55,100 | +116.1% |
| 2026-02-13 15:00 | 2026-02-11 | ONCY | ONCOLYTICS BIOTECH INC | Seizinger Bernd R. | Director | Pharmaceutical Preparations | BUY | $0.83 | 100,000 | $83,450 | 566,991 | +21.4% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Hagerman Allison | Officer - VP, Product Development | Pharmaceutical Preparations | BUY | $0.83 | 10,000 | $8,298 | 115,059 | +9.5% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Brown Deborah Margaret | Director | Pharmaceutical Preparations | BUY | $0.85 | 25,000 | $21,240 | 109,851 | +29.5% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Heineman Thomas Charles | Officer - Chief Medical Officer | Pharmaceutical Preparations | BUY | $0.83 | 12,132 | $10,033 | 282,818 | +4.5% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Pisano Wayne | Director | Pharmaceutical Preparations | BUY | $0.84 | 30,000 | $25,338 | 492,414 | +6.5% |
| 2026-02-13 15:00 | 2026-02-12 | ONCY | ONCOLYTICS BIOTECH INC | Look Kirk | Officer - Chief Financial Officer | Pharmaceutical Preparations | BUY | $0.84 | 12,000 | $10,104 | 287,515 | +4.4% |
| 2026-02-13 15:00 | 2026-02-11 | ONCY | ONCOLYTICS BIOTECH INC | Kelly Jared | Director, Officer - Chief Executive Officer | Pharmaceutical Preparations | BUY | $0.84 | 35,100 | $29,519 | 109,000 | +47.5% |
| 2026-02-13 15:00 | 2026-02-11 | PSEC | PROSPECT CAPITAL CORP | Eliasek M Grier | Director, Officer - Chief Operating Officer | Other | BUY | $2.92 | 942,800 | $2,749,770 | 3,443,930 | +37.7% |
| 2026-02-13 00:22 | 2026-02-11 | TSI | TCW STRATEGIC INCOME FUND INC | McMillan Peter | Director | Other | BUY | $4.73 | 190,000 | $898,776 | 200,000 | +1,900.0% |
| 2026-02-13 03:53 | 2026-02-11 | CGC | Canopy Growth Corp | Mongeau Luc | Director, Officer - Chief Executive Officer | Medicinal Chemicals & Botanical Products | SELL | $1.06 | 9,376 | -$9,951 | 802,992 | -1.2% |
| 2026-02-13 02:24 | 2026-02-10 | NPWR | NET Power Inc. | NPEH, LLC | 10% owner | Electrical Industrial Apparatus | SELL | $2.04 | 250,000 | -$509,175 | 950,000 | -20.8% |
| 2026-02-13 02:25 | 2026-02-10 | NPWR | NET Power Inc. | 8 Rivers Capital, LLC | 10% owner | Electrical Industrial Apparatus | SELL | $2.04 | 250,000 | -$509,175 | 950,000 | -20.8% |
| 2026-02-13 01:19 | 2026-02-10 | TNYA | Tenaya Therapeutics, Inc. | COLUMN GROUP III GP, LP | 10% owner | Biological Products, (No Diagnostic Substances) | SELL | $0.69 | 4,400,290 | -$3,042,361 | 2,651,817 | -62.4% |
| 2026-02-13 01:20 | 2026-02-10 | CSAI | CLOUDASTRUCTURE, INC. | Bentley Sheldon Richard | 10% owner, Other | Services-Computer Programming, Data Processing, Etc. | SELL | $0.61 | 50,000 | -$30,500 | 0 | -100.0% |
| 2026-02-13 00:55 | 2026-02-10 | UWMC | UWM Holdings Corp | Mat Ishbia | Director, Officer, 10% owner - President and CEO | Mortgage Bankers & Loan Correspondents | SELL | $4.74 | 1,898,622 | -$8,999,468 | 1,793,651 | -51.4% |
| 2026-02-13 00:41 | 2026-02-10 | STAI | ScanTech AI Systems Inc. | SEAPORT GLOBAL ASSET MANAGEMENT LLC | 10% owner | Instruments For Meas & Testing of Electricity & Elec Signals | SELL | $0.49 | 70,000 | -$34,118 | 731,867 | -8.7% |
| 2026-02-13 00:42 | 2026-02-10 | SEMR | SEMrush Holdings, Inc. | Shchegolev Oleg | Director, Officer, 10% owner - Chief Technology Officer | Services-Prepackaged Software | BUY | $0.00 | 144,000 | $0 | 3,282,040 | +4.6% |
| 2026-02-13 00:47 | 2026-02-10 | SEMR | SEMrush Holdings, Inc. | Melnikov Dmitry | Director, 10% owner | Services-Prepackaged Software | BUY | $0.00 | 66,667 | $0 | 1,946,479 | +3.5% |
| 2026-02-13 00:31 | 2026-02-10 | STIM | Neuronetics, Inc. | Sullivan Keith J | Director, Officer - President and CEO | Surgical & Medical Instruments & Apparatus | SELL | $1.55 | 40,976 | -$63,513 | 1,567,012 | -2.5% |
| 2026-02-13 00:32 | 2026-02-10 | STIM | Neuronetics, Inc. | MACAN WILLIAM ANDREW | Officer - EVP, CLO and CS | Surgical & Medical Instruments & Apparatus | SELL | $1.55 | 3,485 | -$5,402 | 687,681 | -0.5% |
| 2026-02-13 00:12 | 2026-02-10 | FIEE | FiEE, Inc. | Elements Corporate Services Ltd | 10% owner | Telephone & Telegraph Apparatus | BUY | $1.29 | 2,138,181 | $2,758,253 | 3,119,830 | +217.8% |
| 2026-02-12 22:20 | - | COSM | Cosmos Health Inc. | Siokas Grigorios | Director, Officer, 10% owner - Chief Executive Officer | Wholesale-Drugs, Proprietaries & Druggists' Sundries | BUY | $0.41 | 291,262 | $120,000 | 8,473,382 | +3.6% |
| 2026-02-12 18:58 | 2026-02-11 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.65 | 1,134 | $3,005 | 65,564 | +1.8% |
| 2026-02-12 18:05 | 2026-02-12 | IRIX | IRIDEX CORP | Dizon Romeo R | Officer - Chief Financial Officer | Electromedical & Electrotherapeutic Apparatus | BUY | $1.43 | 1,500 | $2,145 | 117,690 | +1.3% |
| 2026-02-12 00:38 | 2026-02-09 | DLPN | Dolphin Entertainment, Inc. | O'Dowd William IV | Director, Officer - Chief Executive Officer | Services-Personal Services | BUY | $1.64 | 3,000 | $4,920 | 434,690 | +0.7% |
| 2026-02-12 02:52 | 2026-01-14 | FEED | ENvue Medical, Inc. | Glibert Christian Michael | 10% owner | Orthopedic, Prosthetic & Surgical Appliances & Supplies | BUY | $2.67 | 240,000 | $640,800 | 240,000 | +100.0% |
| 2026-02-12 01:11 | 2026-02-09 | LAW | CS Disco, Inc. | Offerdahl James | Director | Services-Prepackaged Software | BUY | $3.99 | 3,000 | $11,970 | 223,652 | +1.4% |
| 2026-02-12 00:30 | 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | Carter Todd Alfred | Officer - Chief Scientific Officer | Biological Products, (No Diagnostic Substances) | SELL | $3.85 | 3,525 | -$13,571 | 153,193 | -2.2% |
| 2026-02-12 00:30 | 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | Sandrock Alfred | Director, Officer - President and CEO | Biological Products, (No Diagnostic Substances) | SELL | $3.78 | 12,192 | -$46,086 | 509,989 | -2.3% |
| 2026-02-12 00:32 | 2026-02-10 | VYGR | Voyager Therapeutics, Inc. | Swartz Robin | Officer - COO & CBO | Biological Products, (No Diagnostic Substances) | SELL | $3.85 | 4,569 | -$17,591 | 210,078 | -2.1% |
| 2026-02-11 21:34 | 2025-12-31 | PFBX | PEOPLES FINANCIAL CORP /MS/ | FULMER A WES | Officer - Executive Vice President | State Commercial Banks | BUY | $0.00 | 160 | $0 | 11,317 | +1.4% |
| 2026-02-11 20:34 | 2026-02-10 | RCG | RENN Fund, Inc. | STAHL MURRAY | Officer, 10% owner - President/Co-Portfolio Manager | Other | BUY | $2.71 | 1,134 | $3,073 | 65,482 | +1.8% |
| 2026-02-11 16:42 | 2026-02-09 | ENTX | Entera Bio Ltd. | Ellis Sean | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.24 | 18,000 | $22,320 | 178,098 | +11.2% |
| 2026-02-11 16:44 | 2026-02-09 | ENTX | Entera Bio Ltd. | Rubin Steven D | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.20 | 10,000 | $12,000 | 10,000 | +100.0% |
| 2026-02-11 16:45 | 2026-02-10 | ENTX | Entera Bio Ltd. | Germano Geno J | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.49 | 20,000 | $29,800 | 0 | +100.0% |
| 2026-02-11 16:47 | 2026-02-10 | ENTX | Entera Bio Ltd. | Taitel Haya | Director | Biological Products, (No Diagnostic Substances) | BUY | $1.48 | 7,500 | $11,100 | 0 | +100.0% |
| 2026-02-11 14:08 | 2026-02-05 | LEE | LEE ENTERPRISES, Inc | Quint Digital Ltd | 10% owner | Newspapers: Publishing or Publishing & Printing | BUY | $3.25 | 2,451,346 | $7,966,875 | 3,214,346 | +321.3% |
High Risk, High Reward Insider Trades
Penny stocks are notoriously volatile, but when insiders put their own money into stocks priced under $5, it provides a unique layer of validation. Unlike large-cap stocks where buys might be routine, a million-share purchase at $0.50 can indicate that management sees a path to recovery or exponential growth. Our tracking allows you to identify ini speculative signals in real-time, focusing on the capital flow of those with intimate industry knowledge. Following these low-cap moves helps bridge the information gap in the most volatile market segments.
Identifying Legitimate Micro-Cap Conviction
Our Penny Stock Filter isolates the most speculative yet promising filings from the SEC Form 4 feed. By focusing on low-priced equities, we highlight where CEOs and Directors are taking meaningful positions. This list is essential for small-cap investors looking to follow the capital of those with intimate knowledge of a company's research, patents, or upcoming regulatory approvals. Eliminate the noise and focus strictly on high-impact accumulation from leadership betting big on their company’s future value in the micro-cap space.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.